Cargando…

Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study

BACKGROUND: Environmental factors play a major role on atopic dermatitis (AD) which shows a constant rise in prevalence in western countries over the last decades. The Hygiene Hypothesis suggesting an inverse relationship between incidence of infections and the increase in atopic diseases in these c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bodemer, Christine, Guillet, Gerard, Cambazard, Frederic, Boralevi, Franck, Ballarini, Stefania, Milliet, Christian, Bertuccio, Paola, La Vecchia, Carlo, Bach, Jean-François, de Prost, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363804/ https://www.ncbi.nlm.nih.gov/pubmed/28333952 http://dx.doi.org/10.1371/journal.pone.0161555

Ejemplares similares

Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85
por: Esposito, Susanna, et al.
Publicado: (2022)

Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
por: Ballarini, Stefania, et al.
Publicado: (2022)

Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021)

The OM-85 bacterial lysate: a new tool against SARS-CoV-2?
por: Pivniouk, Vadim, et al.
Publicado: (2023)

Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance
por: TROIANO, GIANMARCO, et al.
Publicado: (2021)

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
por: Antunes, Krist Helen, et al.
Publicado: (2022)

Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art
por: De Benedetto, Fernando, et al.
Publicado: (2013)

Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
por: Koatz, Ana M., et al.
Publicado: (2016)

OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
por: Fang, Lei, et al.
Publicado: (2021)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice
por: Rossi, Giovanni A., et al.
Publicado: (2018)

OM-85 is an immunomodulator of interferon-β production and inflammasome activity
por: Dang, A. T., et al.
Publicado: (2017)

Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response
por: Baladi, S., et al.
Publicado: (1994)

Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study
por: Gao, Jinming, et al.
Publicado: (2021)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

IRF7-Associated Immunophenotypes Have Dichotomous Responses to Virus/Allergen Coexposure and OM-85-Induced Reprogramming
por: de Jong, Emma, et al.
Publicado: (2021)

Overview of atopic dermatitis
por: Kim, Kyu Han
Publicado: (2013)

Atopic dermatitis in adolescence
por: Ricci, Giampaolo, et al.
Publicado: (2011)

Prevention of atopic dermatitis
por: Williams, Hywel C., et al.
Publicado: (2012)

Autoallergy in atopic dermatitis
por: Hradetzky, Susanne, et al.
Publicado: (2015)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Microbiome in atopic dermatitis
por: Wollina, Uwe
Publicado: (2017)

Atopic Dermatitis and Comorbidity
por: Bekić, Sanja, et al.
Publicado: (2020)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

The exposome in atopic dermatitis
por: Stefanovic, Nicholas, et al.
Publicado: (2019)

Dupilumab for atopic dermatitis
Publicado: (2019)

Crisaborole for atopic dermatitis
Publicado: (2019)

Prevention of Atopic Dermatitis
por: WILLIAMS, Hywel C., et al.
Publicado: (2020)

Treatments for atopic dermatitis
por: Ross, Gayle
Publicado: (2023)

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis
por: Liu, Ping, et al.
Publicado: (2016)

Atopic Dermatitis and the Atopic March: What Is New?
por: Patrizi, Annalisa, et al.
Publicado: (2011)

Atopic dermatitis and atopic march: which link?
por: Maiello, Nunzia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cuouuhmjsnv1m37jvkg63fdgki